| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310947C Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics |
| 04/18/2007 | CN1310942C Suppressor gene |
| 04/18/2007 | CN1310937C Sir2 products and activities |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310675C TNF-alpha converting enzyme |
| 04/17/2007 | US7205397 Modulatory polypeptide; for use in the treatment of bone disorders |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205391 Antibody for use in humans therapeutics and diagnostics |
| 04/17/2007 | US7205390 Enzyme |
| 04/17/2007 | US7205389 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2007 | US7205387 polypeptide comprises a hairpin motif of a neurotrophin |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205381 Modulating interferons |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205136 Catalytic antibodies |
| 04/17/2007 | US7205135 Regulation of human adenylate cyclase |
| 04/17/2007 | US7205119 HA-1 antigen |
| 04/17/2007 | US7205117 Cancer detection method and reagents |
| 04/17/2007 | US7205116 5-Fluoro-uracil immunoassay |
| 04/17/2007 | US7204991 Porphyromonas gingivalis recombinant proteins and truncations |
| 04/17/2007 | US7204989 For diagnosis of Hepatitis E virus, use in a vaccine for the prevention of HEV in humans |
| 04/17/2007 | US7204985 Tumor necrosis factor (TNF); antibody inhibitors; immunotherapy; gene therapy |
| 04/17/2007 | US7204984 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 04/17/2007 | US7204982 Compositions and methods for treatment and detection of multiple cancers |
| 04/17/2007 | CA2287902C Isolated nucleic acid molecules encoding ssx family members and uses thereof |
| 04/17/2007 | CA2178642C Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 04/17/2007 | CA2171759C Methods and compositions for high protein production from recombinant dna |
| 04/17/2007 | CA2166292C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 04/17/2007 | CA2162193C Lactoferrin receptor protein |
| 04/17/2007 | CA2149326C Fully impaired consensus kozak sequences for mammalian expression |
| 04/17/2007 | CA2148578C Humanized antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes |
| 04/17/2007 | CA2100690C Megakaryocyte differentiation factor |
| 04/12/2007 | WO2007041635A2 Fc variants with optimized fc receptor binding properties |
| 04/12/2007 | WO2007041317A2 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | WO2007041171A2 Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells |
| 04/12/2007 | WO2007040912A2 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 04/12/2007 | WO2007040636A1 Methods for reducing blood pressure |
| 04/12/2007 | WO2007039963A1 Brain tumor marker for prediction of prognosis of patient with brain tumor and use thereof |
| 04/12/2007 | WO2007039761A2 Crystal structure of cd44 and its use |
| 04/12/2007 | WO2007039714A1 Expression control using antibody expression optimisation sequences |
| 04/12/2007 | WO2007039489A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 04/12/2007 | WO2007039256A2 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | WO2007039193A1 Antibodies against 25-hydroxyvitamin d |
| 04/12/2007 | WO2007039184A2 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones |
| 04/12/2007 | WO2007038876A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | WO2007016240A3 Use of antibody to m-csf |
| 04/12/2007 | WO2007003421A3 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 04/12/2007 | WO2006125921A3 Antibody or antibody fragment coupled with an immunogenic agent |
| 04/12/2007 | WO2006125640A3 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38 |
| 04/12/2007 | WO2006124641A3 Anti-mesothelin antibodies useful for immunological assays |
| 04/12/2007 | WO2006122822A3 High-level expression of recombinant antibody in a mammalian host cell |
| 04/12/2007 | WO2006116451A3 Antibodies with immune effector activity and that internalize in endosialin-positive cells |
| 04/12/2007 | WO2006089209A3 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 04/12/2007 | WO2006074430A3 Biomarkers for melanoma |
| 04/12/2007 | WO2005014795A3 Osteoarthritis biomarkers and uses thereof |
| 04/12/2007 | WO2004072268A3 Pkhdl1, a homolog of the autosomal recessive kidney disease gene |
| 04/12/2007 | WO2004071408A3 Aβ BINDING MOLECULES |
| 04/12/2007 | WO2004024874A8 Antibodies that recognize hyperproliferative cells and methods of making and using same |
| 04/12/2007 | WO2004013287A3 Antibodies against c3a receptor |
| 04/12/2007 | WO2002086079A3 T1r3 a novel taste receptor |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082382 Development of human monoclonal antibodies and uses thereof |
| 04/12/2007 | US20070082371 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/12/2007 | US20070082365 Protein scaffolds for antibody mimics and other binding proteins |
| 04/12/2007 | US20070082364 Antibody and use thereof |
| 04/12/2007 | US20070082361 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/12/2007 | US20070082334 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/12/2007 | US20070082004 Method for removing a proteinaceous component from a liquid-phase surfactant preparation |
| 04/12/2007 | US20070082003 Method for selecting and producing vaccine components and vaccines based thereon |
| 04/12/2007 | US20070082002 Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof |
| 04/12/2007 | US20070082001 Novel engineered superantigen for human therapy |
| 04/12/2007 | US20070081999 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/12/2007 | US20070081998 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases |
| 04/12/2007 | US20070081995 Methods and compositions for targeting IFNAR2 |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | CA2625183A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | CA2625144A1 Expression control using antibody expression optimisation sequences |
| 04/12/2007 | CA2624562A1 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | CA2624189A1 Fc variants with optimized fc receptor binding properties |
| 04/12/2007 | CA2624124A1 Antibodies against 25-hydroxyvitamin d |
| 04/12/2007 | CA2624081A1 Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells |
| 04/12/2007 | CA2623693A1 Methods for reducing blood pressure |
| 04/12/2007 | CA2623685A1 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones |
| 04/12/2007 | CA2623530A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 04/12/2007 | CA2622772A1 Immunomodulatory compositions and uses therefor |
| 04/12/2007 | CA2621371A1 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 04/12/2007 | CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 04/12/2007 | CA2605781A1 Antigen binding molecules having modified fc regions and altered binding to fc receptors |
| 04/11/2007 | EP1772519A1 RNA binding protein and binding site useful for expression of recombinant molecules |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772515A1 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/11/2007 | EP1772465A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 04/11/2007 | EP1771732A2 Taxol immunoassay |
| 04/11/2007 | EP1771557A2 Gdf3 propeptides and related methods |